Compare CURX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CURX | GXAI |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 9.1M |
| IPO Year | 2025 | 2022 |
| Metric | CURX | GXAI |
|---|---|---|
| Price | $0.39 | $1.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.5M | ★ 11.2M |
| Earning Date | 09-09-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,027.00 |
| Revenue This Year | N/A | $42,959.35 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1473.05 |
| 52 Week Low | $0.26 | $1.00 |
| 52 Week High | $9.18 | $2.96 |
| Indicator | CURX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 61.78 |
| Support Level | $0.39 | $1.11 |
| Resistance Level | $0.42 | $1.88 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 29.85 | 48.91 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.